Literature DB >> 29738399

Cost Determinants in the 90-Day Management of Isolated Ankle Fractures at a Large Urban Academic Hospital.

Matthew A Varacallo1, Patrick Mattern, Jonathan Acosta, Nader Toossi, Kevin M Denehy, Susan P Harding.   

Abstract

OBJECTIVES: To determine the independent risk factors associated with increasing costs and unplanned hospital readmissions in the 90-day episode of care (EOC) for isolated operative ankle fractures at our institution.
DESIGN: Retrospective cohort study.
SETTING: Level I Trauma Center. PATIENTS: Two hundred ninety-nine patients undergoing open reduction internal fixation for the treatment of an acute, isolated ankle fracture between 2010 and 2015. INTERVENTION: None. MAIN OUTCOME MEASURES: Independent risk factors for increasing 90-day EOC costs and unplanned hospital readmission rates.
RESULTS: Orthopaedic (64.9%) and podiatry (35.1%) patients were included. The mean index admission cost was $14,048.65 ± $5,797.48. Outpatient cases were significantly cheaper compared to inpatient cases ($10,164.22 ± $3,899.61 vs. $15,942.55 ± $5,630.85, respectively, P < 0.001). Unplanned readmission rates were 5.4% (16/299) and 6.7% (20/299) at 30 and 90 days, respectively, and were often (13/20, 65.0%) due to surgical site infections. Independent risk factors for unplanned hospital readmissions included treatment by the podiatry service (P = 0.024) and an American Society of Anesthesiologists score of ≥3 (P = 0.017). Risk factors for increasing total postdischarge costs included treatment by the podiatry service (P = 0.011) and male gender (P = 0.046).
CONCLUSIONS: Isolated operative ankle fractures are a prime target for EOC cost containment strategy protocols. Our institutional cost analysis study suggests that independent financial clinical risk factors in this treatment cohort includes podiatry as the treating surgical service and patients with an American Society of Anesthesiologists score ≥3, with the former also independently increasing total postdischarge costs in the 90-day EOC. Outpatient procedures were associated with about a one-third reduction in total costs compared to the inpatient subgroup.

Entities:  

Mesh:

Year:  2018        PMID: 29738399     DOI: 10.1097/BOT.0000000000001186

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  6 in total

1.  Implant Charge Differences Between Distal Radius Fixation Constructs (CPT 25607, 25608, and 25609).

Authors:  Avi D Goodman; Jacob M Modest; Joey P Johnson; Roman A Hayda; Christopher J Got; Joseph A Gil; Arnold-Peter C Weiss
Journal:  Hand (N Y)       Date:  2020-10-19

2.  Outpatient surgery in patients with ankle fractures minimises hospital admissions and utilisation of healthcare resources.

Authors:  Travis S Bullock; Jose M Gutierrez-Naranjo; Robert G DelBello; Ravi A Karia; Boris A Zelle
Journal:  Int Orthop       Date:  2020-08-08       Impact factor: 3.075

3.  Complications after fibula intramedullary nail fixation of pilon versus ankle fractures.

Authors:  Rachel M Faber; Joshua A Parry; George H Haidukewych; Kenneth J Koval; Joshua L Langford
Journal:  J Clin Orthop Trauma       Date:  2021-01-07

Review 4.  Octogenarian and Nonagenarians Are at a Higher Risk for Experiencing Adverse 30-Day Outcomes Following ORIF of Ankle Fractures.

Authors:  Mitchell T Gray; Krystin A Hidden; Azeem T Malik; Safdar N Khan; Laura Phieffer; Thuan V Ly; Carmen E Quatman
Journal:  Geriatr Orthop Surg Rehabil       Date:  2021-05-04

5.  The Use of Antibiotics for the Prevention of Surgical Site Infections in Two Government Hospitals in Taif, Saudi Arabia: A Retrospective Study.

Authors:  Omar M Alsaeed; Abdullah A Bukhari; Adel A Alshehri; Faisal A Alsumairi; Anas M Alnami; Hatim A Elsheikh
Journal:  Cureus       Date:  2022-07-11

6.  A cost analysis of ankle fractures treated by orthopedic surgeons with or without foot and ankle fellowship training at ambulatory surgery centers and hospitals.

Authors:  Matthew Barfield; J Benjamin Jackson; Tyler Gonzalez
Journal:  SAGE Open Med       Date:  2022-10-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.